首页 | 本学科首页   官方微博 | 高级检索  
     

阿托伐他汀对颅脑外伤后小胶质细胞激活的影响
引用本文:郁龚杰,孙东东,曾勇,高伟伟,陈思亲,张建宁. 阿托伐他汀对颅脑外伤后小胶质细胞激活的影响[J]. 天津医药, 2016, 44(4): 438-440. DOI: 10.11958/20150279
作者姓名:郁龚杰  孙东东  曾勇  高伟伟  陈思亲  张建宁
作者单位:1天津医科大学总医院神经外科, 天津市神经病学研究所 (邮编300052); 2天津医科大学基础医学研究中心转化肿瘤实验室
基金项目:国家自然科学基金面上项目(81271361);国家自然科学基金重点项目(81330029)
摘    要:摘要: 目的 观察阿托伐他汀对颅脑损伤 (TBI) 后小胶质细胞激活的影响。方法 将 60 只 C57/BL6 小鼠随机分为假手术组、 生理盐水组和阿托伐他汀组, 各 20 只。生理盐水组和阿托伐他汀组采用液压打击法制作 TBI 模型。假手术组不进行液压打击。阿托伐他汀组打击后 1 h 给予阿托伐他汀 (每天 1 mg/kg) 灌胃, 连续 7 d。生理盐水组给予等量生理盐水灌胃。采用免疫组化法检测造模后第 1、 3、 7 天创伤灶周围小胶质细胞特异性标志物 (Iba-1) 的数量及第 3 天基质金属蛋白酶 (MMP) -9 水平; Western blot 检测炎症因子肿瘤坏死因子 (TNF) -α水平。结果 造模后第 1、 3、 7 天, 阿托伐他汀组小鼠创伤灶周围 Iba-1 阳性表达量较生理盐水组均显著降低 (80.00±7.44 vs. 118.40± 6.65, 85.60±10.87 vs. 189.00±7.51, 69.40±5.54 vs. 102.40±10.89, P<0.05)。TBI 后第 3 天, 阿托伐他汀组 MMP-9 阳性表达量与生理盐水组相比也显著下降 (86.80±8.40 vs. 133.80±8.46, P<0.05); Western blot 检测发现阿托伐他汀组与生理盐水组相比 TNF-α表达下降 (0.64±0.01 vs. 0.97±0.02, P<0.05)。结论 阿托伐他汀能减少小鼠 TBI 后小胶质细胞的激活, 减少炎症因子的表达, 起到抗炎作用。

关 键 词:颅脑损伤  小神经胶质细胞  基质金属蛋白酶 9  肿瘤坏死因子α  阿托伐他汀  
收稿时间:2015-11-02
修稿时间:2015-11-30

Effects of atorvastatin on the microglia activation after traumatic brain injury
YU Gongjie;SUN Dongdong;ZENG Yong;GAO Weiwei;CHEN Siqin;ZHANG Jianning. Effects of atorvastatin on the microglia activation after traumatic brain injury[J]. Tianjin Medical Journal, 2016, 44(4): 438-440. DOI: 10.11958/20150279
Authors:YU Gongjie  SUN Dongdong  ZENG Yong  GAO Weiwei  CHEN Siqin  ZHANG Jianning
Affiliation:1 Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Tianjin 300052, China; 2 Research Center of Basic Medical Sciences, Tianjin Medical University
Abstract:Abstract: Objective To observe the effects of atorvastatin on the microglia activation after traumatic brain injury (TBI). Methods Sixty adult male C57/BL6 mice were randomly divided into sham group, atorvastatin group and saline group, 20 mice for each group. The atorvastatin group and saline group were given hydraulic combat to establish TBI mouse model. The shame group underwent the same surgical procedure without being exposed to percussion injury. The atorvastatin group was treated with atorvastatin (orally, 1 mg/kg)1 h after TBI and for 7 consecutive days. The saline group was given sa⁃ line orally. The expression of microglia (Iba-1+ ) at the 1st, 3rd, and 7th day after TBI and matrix metalloproteinase -9 (MMP- 9) around the lesion at the 3rd day after TBI were detected by immunohistochemical staining. Tumor necrosis factor (TNF)-α was detected by Western blot assay at the 3rd day after TBI. Results The positive expression of Iba-1+ microglia was signifi⁃ cantly decreased in atorvastatin group than that of saline group at the 1st, 3rd, and 7th day after TBI (80.00±7.44 vs. 118.40± 6.65, 85.60±10.87 vs. 189.00±7.51, 69.40±5.54 vs. 102.40±10.89, P<0.05). The positive expression of MMP-9 was signifi⁃ cantly decreased in atorvastatin group compared with that of saline group at the 3rd day after TBI (86.80±8.40 vs. 133.80± 8.46, P<0.05). Results of Western blot assay showed that the positive expression of TNF-α was significantly decreased in astorvastatin group than that of saline group at the 3rd day after TBI (0.64±0.01 vs. 0.97±0.02, P<0.05). Conclusion Ator⁃ vastatin can reduce inflammation factor by influencing the microglia activation after TBI in mice.
Keywords:craniocerebral trauma  microglia  matrix metalloproteinase 9  tumor necrosis factor-alpha  Atorvastatin  
本文献已被 CNKI 等数据库收录!
点击此处可从《天津医药》浏览原始摘要信息
点击此处可从《天津医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号